Clinical exam
Otherclinical oral examination
NCT Number: NCT04217538
Hereditary Epidermolysis Bullosa (EBH) are rare dermatologic diseases characterized by cutaneous and mucosa fragility. Oral manifestations of few small cohort have been published. The main objective of this multicentric cohort study first in Europe was to report the oral status of these patients that were consulted in the MRDRC of this disease in Nice (France), Toulouse (France) and Louvain (Belgium). Then a correlation between the oral characteristics and the EBH type will be made, in order to facilitate the management of patient care and the prevention program that can be established to improve their oral health.
Looking for future studies?
Notify Me7 month–78 year
All sexes
Observational
Nice Hospital, Nice, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
clinical oral examination
Time frame: 1 day
number of defect /dental caries dor each toth
Time frame: 1 day
clinical observation of gingiva (thin or thick)
Time frame: 1 day
observation and classification of the gingiva (healthy, inflammed or hyperplastic)
Time frame: 1 day
registration of plaque and gingival index according to the Loë and Silness method
Time frame: 1 day
number and localisation of the blister/scars/flanges scars on a sketch of a mouth
Centre Hospitalier Universitaire de Nice
Other
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa That Come for Their Annual/Biannual Check up at This Medical Rare Disease Reference Centers (MRDRC) of This Disease in France and Belgium
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04853667
Agnosia, Congenital Abnormalities
Paris, France
View Trial DetailsNCT03730584
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Paris, France
View Trial DetailsNCT05533866
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Chicago, Illinois, United States
View Trial DetailsNCT03928093
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Toronto, Ontario, Canada
View Trial Details